51655-0196 Ondansetron

Product NDC:

51655-0196

Brand Name:

Ondansetron

Generic Name:

Ondansetron

Dosage Form Name:

TABLET, ORALLY DISINTEGRATING

Administration Route:

Oral

Substances:

Name: ONDANSETRON

Strength: 8.0

Unit: mg/1

Packages:

Code: 51655-0196-53

Description: 10 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-53)

Effective Date: July 20, 2022

Discontinued:

Code: 51655-0196-80

Description: 8 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-80)

Effective Date: July 20, 2022

Discontinued:

Code: 51655-0196-87

Description: 6 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-87)

Effective Date: March 13, 2023

Discontinued:

Code: 51655-0196-04

Description: 4 TABLET, ORALLY DISINTEGRATING in 1 BAG (51655-196-04)

Effective Date: April 27, 2023

Discontinued:

SEER*Rx Category:

Ancillary Therapy

Major Class:

Antiemetic

Minor Class:

5HT3 Receptor Antagonist

Orphan Drug Designation:

No

Status:

In Use

CanMED and the Oncology Toolbox